User login
- /content/no-acs-approvals-rivaroxaban-janssen-announces
- /emed-journal/article/80422/acute-coronary-syndromes/no-acs-approvals-rivaroxaban-janssen-announces
- /ehospitalistnews/article/80422/acute-coronary-syndromes/no-acs-approvals-rivaroxaban-janssen
- /internalmedicinenews/article/80422/acute-coronary-syndromes/no-acs-approvals-rivaroxaban-janssen
- /ecardiologynews/article/80422/acute-coronary-syndromes/no-acs-approvals-rivaroxaban-janssen
- /cardiology/article/80422/acute-coronary-syndromes/no-acs-approvals-rivaroxaban-janssen-announces
- /internalmedicine/article/80422/acute-coronary-syndromes/no-acs-approvals-rivaroxaban-janssen
- /emergencymedicine/article/80422/acute-coronary-syndromes/no-acs-approvals-rivaroxaban-janssen
- /chestphysician/article/80422/acute-coronary-syndromes/no-acs-approvals-rivaroxaban-janssen-announces